这是描述信息

Latest News

Huawu Pharmaceutical's API production line has passed the GMP certification of the World Health Organization (WHO)
Huawu Pharmaceutical's API production line has passed the GMP certification of the World Health Organization (WHO)
On August 7, 2015, the company successfully passed the GMP certification of the World Health Organization (WHO). This is the first GMP certification obtained by the WHO after the company's relocation, marking the company's quality management level and operating performance to a new level.
See more information
On August 7, 2015, the company successfully passed the GMP certification of the World Health Organization (WHO). This is the first GMP certification obtained by the WHO after the company's relocation, marking the company's quality management level and operating performance to a new level.
/
/
/
Kunyao Group Chongqing Wulingshan Pharmaceutical Co., Ltd. Reconstruction and Expansion Project Environmental Impact Assessment Public Participation First Public Announcement
Check category

Kunyao Group Chongqing Wulingshan Pharmaceutical Co., Ltd. Reconstruction and Expansion Project Environmental Impact Assessment Public Participation First Public Announcement

  • Categories:Company News
  • Author:
  • Origin:
  • Time of issue:2018-10-08 15:42
  • Views:0

(Summary description)According to the relevant provisions of the "Interim Measures for Public Participation in Environmental Impact Assessment," combined with the characteristics of the construction project, the relevant information about the "Reconstruction and Expansion Project of Kunyao Group Chongqing Wulingshan Pharmaceutical Co., Ltd." is now publicized for the first time

Kunyao Group Chongqing Wulingshan Pharmaceutical Co., Ltd. Reconstruction and Expansion Project Environmental Impact Assessment Public Participation First Public Announcement

(Summary description)According to the relevant provisions of the "Interim Measures for Public Participation in Environmental Impact Assessment," combined with the characteristics of the construction project, the relevant information about the "Reconstruction and Expansion Project of Kunyao Group Chongqing Wulingshan Pharmaceutical Co., Ltd." is now publicized for the first time

  • Categories:Company News
  • Author:
  • Origin:
  • Time of issue:2018-10-08 15:42
  • Views:0
Information
Kunyao Group Chongqing Wulingshan Pharmaceutical Co., Ltd. Reconstruction and Expansion Project Environmental Impact Assessment Public Participation First Public Announcement
  According to the relevant provisions of the "Interim Measures for Public Participation in Environmental Impact Assessment," combined with the characteristics of the construction project, the relevant information about the "Reconstruction and Expansion Project of Kunyao Group Chongqing Wulingshan Pharmaceutical Co., Ltd." is now publicized for the first time.
  (1) Name and outline of construction project
  Project name: Kunming Pharmaceutical Group Chongqing Wulingshan Pharmaceutical Co., Ltd. Reconstruction and Expansion Project
  Construction site: No. 108, Jinyuan Avenue South Road, Banxi Light Industrial Park, Youyang County, Chongqing
  Project construction content: 700t/a of hesperidin extracted by alcohol, 300t/a of hesperidin extracted by water, 12 million boxes/a of hesperidin (100mL/box), sewage treatment station 800m3/d, 600㎡ tank area, 200㎡ Boiler room and related supporting facilities and equipment.
  (2) The name and contact information of the construction unit
  Construction unit: Kunyao Group Chongqing Wulingshan Pharmaceutical Co., Ltd.
  Contact: Minister Liu
  Tel: 13709496777
  Email: 273800777@qq.com
  Address: No. 108, Jinyuan Avenue South Road, Banxi Light Industrial Park, Youyang County, Chongqing
  (3) The name and contact information of the environmental impact assessment agency undertaking the assessment
  Unit name: Zhonghuan Lianxin (Beijing) Environmental Protection Co., Ltd.
  Certificate Number: National Environmental Assessment Certificate No. 1058
  Contact: Wu Gong
  Tel: 023-68075970
  Email: 283535161@qq.com (Please specify the subject of the email: Public Opinions on the Reconstruction and Expansion Project of Chongqing Wulingshan Pharmaceutical Co., Ltd. of Kunyao Group)
  Address: 3109, Building 5, Shidaitian Street, Longhu, Yuzhong District, Chongqing
  (4) Environmental impact assessment work procedures and main work content
  Work procedures: data collection→site survey and preliminary investigation→engineering analysis→status investigation and monitoring→environmental impact forecast analysis and evaluation→effectiveness analysis of environmental protection measures→report preparation→submission review
  Work content: by investigating the current environmental status of the project and surrounding areas, evaluating regional environmental characteristics, analyzing the environmental impact factors that may occur during the construction of the project, predicting and analyzing the impact of the pollution factors existing in the project on the environment, and proposing effective measures to mitigate the environmental impact .
  (5) Scope and main items for soliciting public opinions
  Solicit public opinions and suggestions on the environmental impact of construction projects, pollution prevention measures, etc.
  (6) The way and time limit for public comments
  The public can put forward their own opinions and suggestions to the local environmental protection authority, the environmental impact assessment unit of this project or the construction unit by telephone, email or mail.
  Opinion feedback deadline: within 10 working days from the date of this announcement.
October 8, 2018
Kunyao Group Chongqing Wulingshan Pharmaceutical Co., Ltd.
1

Scan the QR code to read on your phone

地址版权

Time of issue:2019-05-10 00:00:00

Tel:+86-023-75580601  Fax:+86-023-64755388  Address:No. 108 Jinyuan Avenue South Road, Banxi Light Industry Park, Youyang County, Chongqing.

© 2020 Holleypharm All Rights Reserved.  渝ICP备13002270号-1  Powered by:www.300.cn

地址版权手机

Time of issue:2019-05-10 00:00:00

© 2020 Holleypharm All Rights Reserved.

渝ICP备13002270号-1  Powered by:www.300.cn

QR code
Online customer service
Customer service hotline
+86-023-75580601
Service time:
9:00 - 18:00
Customer service group:
Online